| PDAC | Pancreatic ductal adenocarcinoma |
| FUS | Focused ultrasound |
| HIFU | High-intensity focused ultrasound |
| pHIFU | Pulsed high-intensity focused ultrasound |
| LIFU | Low-intensity focused ultrasound |
| US | Ultrasound |
| MRI | Magnetic resonance imaging |
| MRIgFUS | Magnetic resonance-guided focused ultrasound |
| EUS | Endoscopic ultrasound |
| EUS-FUS | Endoscopic ultrasound-guided focused ultrasound |
| CT | Computed tomography |
| TME | Tumor microenvironment |
| ICD | Immunogenic cell death |
| TAA | Tumor-associated antigen |
| DAMP | Damage-associated molecular pattern |
| IRE | Irreversible electroporation |
| RFA | Radiofrequency ablation |
| MWA | Microwave ablation |
| SBRT | Stereotactic body radiation therapy |
| GEMM | Genetically engineered mouse model |
| ISPPA | Spatial peak pulse average intensity |
| MPa | Megapascal |
| ROS | Reactive oxygen species |
| PD-1 | Programmed cell death protein-1 |
| PD-L1 | Programmed death-ligand 1 |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |